Skip to content

Clinical trials

Completed Diabetes Mellitus, Type 2 trials in Latvia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Status: Completed Country / region: Latvia Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20031
20053
20063
20074
20082
20097
20105
20112
20124
20134
20141
20151
20163
20171
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S6
Takeda6
GlaxoSmithKline5
Hoffmann-La Roche5
Sanofi5
AstraZeneca4
Boehringer Ingelheim4
Novartis Pharmaceuticals3
Janssen Research & Development, LLC2
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 246
Diabetes Mellitus12
Glucose Metabolism Disorders5
Cardiovascular Diseases4
Dyslipidemias3
Glucose Intolerance3
Hyperglycemia3
Metabolic Diseases3
Diabetes Mellitus, Lipoatrophic2
Renal Insufficiency2

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.